KPI is a clinical-stage biopharma company focused on the development of new medicines that have the potential to transform the standard of care and save or improve patients’ lives. Our pipeline includes TriRima, a reversible inhibitor of monoamine oxidase-A (RIMA) for the treatment of depression, and KP544, a novel mechanism for the treatment of neurodegenerative disorders such as Alzheimer's Disease and prevention of neuropathy caused by chemotherapeutic agents.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Research Triangle Par,, Nc, Us
- kp****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- kpipharma.com
- HQ
- Research Triangle Par,, NC
- Competitors
- Kartha Pharmaceuticals Inc.
Krenitsky Pharmaceuticals Questions
Krenitsky Pharmaceuticals's website is kpipharma.com
Krenitsky Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/krenitsky-pharmaceuticals
Krenitsky Pharmaceuticals has
4 employees.
View email and phone details for 4
employees at Krenitsky Pharmaceuticals.
Krenitsky Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Krenitsky Pharmaceuticals's top competitors are
Kartha Pharmaceuticals Inc.
Krenitsky Pharmaceuticals's support email address is kpi@kpi-pharma.com
Krenitsky Pharmaceuticals's categories are Pharmaceutical Manufacturing
Krenitsky Pharmaceuticals's founding year is 1995
